人工智能在卵巢癌诊断与治疗中的应用进展: 从影像识别到精准医学
The Application Progress of Artificial Intelligence in the Diagnosis and Treatment of Ovarian Cancer: From Image Recognition to Precision Medicine
摘要: 卵巢癌作为女性生殖系统中致死率较高的恶性肿瘤之一,其早期诊断和精准治疗一直是临床研究的重点难题。近年来,人工智能技术的迅猛发展为卵巢癌的诊断与治疗带来了新的机遇。本文综述了人工智能技术在卵巢癌领域的最新应用进展,尤其聚焦基于机器学习和深度学习的影像识别、病理分析、基因组学研究及生物标志物发现等方面。通过整合多模态数据,人工智能技术显著提升了卵巢癌早期检测的准确性和病理分类的精细度,为预后评估和药物耐药性分析提供了有力支持,推动了个性化精准医疗的发展。然而,数据质量良莠不齐、模型的可解释性不足及临床应用的转化难题仍限制了人工智能技术的广泛应用。未来,随着多学科融合和技术优化,人工智能技术有望在卵巢癌诊疗中发挥更大作用,实现更精准、高效的临床决策支持。
Abstract: Ovarian cancer, as one of the malignant tumors with a relatively high mortality rate in the female reproductive system, its early diagnosis and precise treatment have always been key challenges in clinical research. In recent years, the rapid development of artificial intelligence technology has brought new opportunities for the diagnosis and treatment of ovarian cancer. This article reviews the latest application progress of artificial intelligence technology in the field of ovarian cancer, with a particular focus on aspects such as image recognition, pathological analysis, genomic research, and biomarker discovery based on machine learning and deep learning. By integrating multimodal data, artificial intelligence technology has significantly enhanced the accuracy of early detection of ovarian cancer and the fineness of pathological classification, providing strong support for prognosis assessment and drug resistance analysis, and promoting the development of personalized precision medicine. However, the uneven quality of data, the insufficient interpretability of models, and the challenges in transforming them into clinical applications still limit the wide application of artificial intelligence technology. In the future, with the integration of multiple disciplines and technological optimization, artificial intelligence technology is expected to play a greater role in the diagnosis and treatment of ovarian cancer, achieving more precise and efficient clinical decision support.
文章引用:于甜甜, 刘金荣, 刘晓燕. 人工智能在卵巢癌诊断与治疗中的应用进展: 从影像识别到精准医学[J]. 临床医学进展, 2026, 16(2): 2187-2195. https://doi.org/10.12677/acm.2026.162618

参考文献

[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[2] Mi, S., Zhang, L., Li, M., Dong, Z., Tian, C. and Fu, M. (2022) Expression of Enhancer-Binding Protein CEBPA mRNA and Protein in Ovarian Cancer and Its Relationship with Pathobiological Characteristics. Frontiers in Surgery, 9, Article ID: 842823. [Google Scholar] [CrossRef] [PubMed]
[3] Rong, Y. and Li, L. (2021) Early Clearance of Serum HE4 and CA125 in Predicting Platinum Sensitivity and Prognosis in Epithelial Ovarian Cancer. Journal of Ovarian Research, 14, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, X., Wang, X., Zhang, K., Fung, K., Thai, T.C., Moore, K., et al. (2022) Recent Advances and Clinical Applications of Deep Learning in Medical Image Analysis. Medical Image Analysis, 79, Article ID: 102444. [Google Scholar] [CrossRef] [PubMed]
[5] Cai, G., Huang, F., Gao, Y., Li, X., Chi, J., Xie, J., et al. (2024) Artificial Intelligence-Based Models Enabling Accurate Diagnosis of Ovarian Cancer Using Laboratory Tests in China: A Multicentre, Retrospective Cohort Study. The Lancet Digital Health, 6, e176-e186. [Google Scholar] [CrossRef] [PubMed]
[6] Asaturova, A., Pinto, J., Polonia, A., Karpulevich, E., Mattias-Guiu, X. and Eloy, C. (2025) Artificial Intelligence Tools for Supporting Histopathologic and Molecular Characterization of Gynecological Cancers: A Review. Journal of Clinical Medicine, 14, Article No. 7465. [Google Scholar] [CrossRef
[7] Chae, S.H., Lee, C., Yoon, S., Shim, S., Lee, S.J., Kim, S., et al. (2021) Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer. Journal of Korean Medical Science, 36, e2. [Google Scholar] [CrossRef] [PubMed]
[8] He, Y., Li, T., Liu, J., Ou, Q. and Zhou, J. (2020) Early Onset Neutropenia: A Useful Predictor of Chemosensitivity and Favorable Prognosis in Patients with Serous Ovarian Cancer. BMC Cancer, 20, Article No. 116. [Google Scholar] [CrossRef] [PubMed]
[9] Kim, J.Y., Shin, H., Haque, R., Kang, E. and Kim, J. (2025) PLCD1 Expression for Early Detection and Prognosis in High-Grade Serous Ovarian Cancer. BMC Cancer, 25, Article No. 1741. [Google Scholar] [CrossRef
[10] Song, G., Sun, Z., Chu, M., Zhang, Z., Chen, J., Wang, Z., et al. (2024) FBXO28 Promotes Cell Proliferation, Migration and Invasion via Upregulation of the TGF-beta1/SMAD2/3 Signaling Pathway in Ovarian Cancer. BMC Cancer, 24, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
[11] Afnouch, M., Bougourzi, F., Gaddour, O., Dornaika, F. and Ahmed, A.T. (2025) Artificial Intelligence in Bone Metastasis Analysis: Current Advancements, Opportunities and Challenges. Computers in Biology and Medicine, 194, Article ID: 110372. [Google Scholar] [CrossRef] [PubMed]
[12] Zhou, Z., Qian, X., Hu, J., Chen, G., Zhang, C., Zhu, J., et al. (2023) An Artificial Intelligence-Assisted Diagnosis Modeling Software (AIMS) Platform Based on Medical Images and Machine Learning: A Development and Validation Study. Quantitative Imaging in Medicine and Surgery, 13, 7504-7522. [Google Scholar] [CrossRef] [PubMed]
[13] Sadeghi, M.H., Sina, S., Omidi, H., Farshchitabrizi, A.H. and Alavi, M. (2024) Deep Learning in Ovarian Cancer Diagnosis: A Comprehensive Review of Various Imaging Modalities. Polish Journal of Radiology, 89, e30-e48. [Google Scholar] [CrossRef] [PubMed]
[14] Su, C., Miao, K., Zhang, L., Yu, X., Guo, Z., Li, D., et al. (2025) Multimodal Deep Learning Based on Ultrasound Images and Clinical Data for Better Ovarian Cancer Diagnosis. Journal of Imaging Informatics in Medicine. [Google Scholar] [CrossRef] [PubMed]
[15] Du, Y., Wang, T., Qu, L., Li, H., Guo, Q., Wang, H., et al. (2024) Preoperative Molecular Subtype Classification Prediction of Ovarian Cancer Based on Multi-Parametric Magnetic Resonance Imaging Multi-Sequence Feature Fusion Network. Bioengineering, 11, Article No. 472. [Google Scholar] [CrossRef] [PubMed]
[16] Dai, W.L., Wu, Y.N., Ling, Y.T., Zhao, J., Zhang, S., Gu, Z., et al. (2024) Development and Validation of a Deep Learning Pipeline to Diagnose Ovarian Masses Using Ultrasound Screening: A Retrospective Multicenter Study. eClinicalMedicine, 78, Article ID: 102923. [Google Scholar] [CrossRef] [PubMed]
[17] Christiansen, F., Konuk, E., Ganeshan, A.R., Welch, R., Palés Huix, J., Czekierdowski, A., et al. (2025) International Multicenter Validation of AI-Driven Ultrasound Detection of Ovarian Cancer. Nature Medicine, 31, 189-196. [Google Scholar] [CrossRef] [PubMed]
[18] Kalra, S., Tizhoosh, H.R., Shah, S., Choi, C., Damaskinos, S., Safarpoor, A., et al. (2020) Pan-Cancer Diagnostic Consensus through Searching Archival Histopathology Images Using Artificial Intelligence. NPJ Digital Medicine, 3, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[19] Peng, J., He, Q., Wang, C., Wang, Z., Zeng, S., Huang, Q., et al. (2025) OCDet: A Comprehensive Ovarian Cell Detection Model with Channel Attention on Immunohistochemical and Morphological Pathology Images. Computers in Biology and Medicine, 186, Article ID: 109713. [Google Scholar] [CrossRef] [PubMed]
[20] Akazawa, M. and Hashimoto, K. (2021) Artificial Intelligence in Gynecologic Cancers: Current Status and Future Challenges—A Systematic Review. Artificial Intelligence in Medicine, 120, Article ID: 102164. [Google Scholar] [CrossRef] [PubMed]
[21] Asadi-Aghbolaghi, M., Darbandsari, A., Zhang, A., Contreras-Sanz, A., Boschman, J., Ahmadvand, P., et al. (2024) Learning Generalizable AI Models for Multi-Center Histopathology Image Classification. NPJ Precision Oncology, 8, Article No. 151. [Google Scholar] [CrossRef] [PubMed]
[22] Boschman, J., Farahani, H., Darbandsari, A., Ahmadvand, P., Van Spankeren, A., Farnell, D., et al. (2021) The Utility of Color Normalization for AI‐based Diagnosis of Hematoxylin and Eosin‐Stained Pathology Images. The Journal of Pathology, 256, 15-24. [Google Scholar] [CrossRef] [PubMed]
[23] Joshua, A., Allen, K.E. and Orsi, N.M. (2025) An Overview of Artificial Intelligence in Gynaecological Pathology Diagnostics. Cancers, 17, Article No. 1343. [Google Scholar] [CrossRef] [PubMed]
[24] Ayyoubzadeh, S.M., Ahmadi, M., Yazdipour, A.B., Ghorbani‐Bidkorpeh, F. and Ahmadi, M. (2024) Prediction of Ovarian Cancer Using Artificial Intelligence Tools. Health Science Reports, 7, e2203. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, H.L., Li, X.Y., Jia, M., Ma, Q., Zhang, Y., Liu, F., et al. (2025) AI-Derived Blood Biomarkers for Ovarian Cancer Diagnosis: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 27, e67922. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, Q., Zhou, X., Wu, J., Miao, W., Shen, B. and Shi, R. (2025) Research Progress of Artificial Intelligence in the Early Screening, Diagnosis, Precise Treatment and Prognosis Prediction of Three Central Gynecological Malignancies. Frontiers in Oncology, 15, Article ID: 1648407. [Google Scholar] [CrossRef
[27] Wu, Y., Wang, K., Song, Y. and Li, B. (2025) Enhancing Ovarian Cancer Prognosis with an Artificial Intelligence-Derived Model: Multi-Omics Integration and Therapeutic Implications. Translational Oncology, 59, Article ID: 102439. [Google Scholar] [CrossRef] [PubMed]
[28] Elguoshy, A., Zedan, H. and Saito, S. (2025) Machine Learning-Driven Insights in Cancer Metabolomics: From Subtyping to Biomarker Discovery and Prognostic Modeling. Metabolites, 15, Article No. 514. [Google Scholar] [CrossRef] [PubMed]
[29] Tang, S., Sumitra, M.R., Kuo, Y., Hsu, H., Ansar, M., Huang, S., et al. (2025) Computer-Aided Drug Discovery of a Dual-Target Inhibitor for Ovarian Cancer: Therapeutic Intervention Targeting CDK1/TTK Signaling Pathway and Structural Insights in the NCI-60. Computers in Biology and Medicine, 193, Article ID: 110445. [Google Scholar] [CrossRef] [PubMed]
[30] Rana, A.J., Hussain, M.S., Hanbashi, A., Kamli, F., Khan, G., Qadri, M., et al. (2025) CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research. Current Pharmaceutical Design, 31, 1027-1034. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, C., Yang, J., Chen, S., Sun, L., Li, K., Lai, G., et al. (2024) Artificial Intelligence in Ovarian Cancer Drug Resistance Advanced 3PM Approach: Subtype Classification and Prognostic Modeling. EPMA Journal, 15, 525-544. [Google Scholar] [CrossRef] [PubMed]
[32] Wu, H., Ma, L., Wang, L., Zhu, X., Luo, X., Zhang, C., et al. (2025) Development and Validation of Deep Learning for Predicting the Growth of Ovarian Cancer Organoids. Chinese Medical Journal, 139, 108-117. [Google Scholar] [CrossRef] [PubMed]
[33] Liu, Y., Zhang, D., Liu, T., Wang, A., Wang, G. and Zhao, Y. (2025) Graph-Based Deep Learning for Integrating Single-Cell and Bulk Transcriptomic Data to Identify Clinical Cancer Subtypes. Briefings in Bioinformatics, 26, bbaf467. [Google Scholar] [CrossRef
[34] Yang, Z., Zhang, Y., Zhuo, L., Sun, K., Meng, F., Zhou, M., et al. (2024) Prediction of Prognosis and Treatment Response in Ovarian Cancer Patients from Histopathology Images Using Graph Deep Learning: A Multicenter Retrospective Study. European Journal of Cancer, 199, Article ID: 113532. [Google Scholar] [CrossRef] [PubMed]
[35] Laios, A., Kalampokis, E., Johnson, R., Thangavelu, A., Tarabanis, C., Nugent, D., et al. (2022) Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer. Journal of Personalized Medicine, 12, Article No. 607. [Google Scholar] [CrossRef] [PubMed]
[36] Laios, A., Kalampokis, E., Johnson, R., Munot, S., Thangavelu, A., Hutson, R., et al. (2022) Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer. Cancers, 14, Article No. 3447. [Google Scholar] [CrossRef] [PubMed]
[37] Thuraisingam, S., Chondros, P., Dowsey, M.M., Spelman, T., Garies, S., Choong, P.F., et al. (2021) Assessing the Suitability of General Practice Electronic Health Records for Clinical Prediction Model Development: A Data Quality Assessment. BMC Medical Informatics and Decision Making, 21, Article No. 297. [Google Scholar] [CrossRef] [PubMed]
[38] Gonzales, R.A., Ibáñez, D.H., Hann, E., Popescu, I.A., Burrage, M.K., Lee, Y.P., et al. (2023) Quality Control-Driven Deep Ensemble for Accountable Automated Segmentation of Cardiac Magnetic Resonance LGE and VNE Images. Frontiers in Cardiovascular Medicine, 10, Article ID: 1213290. [Google Scholar] [CrossRef] [PubMed]
[39] Xie, S., Cai, H., Sun, Y. and Lv, X. (2025) LLM-DQR: Large Language Model-Based Automated Generation of Data Quality Rules for Electronic Health Records. Journal of Biomedical Informatics, 172, Article ID: 104951. [Google Scholar] [CrossRef
[40] Mitchell, S., Nikolopoulos, M., El-Zarka, A., Al-Karawi, D., Al-Zaidi, S., Ghai, A., et al. (2024) Artificial Intelligence in Ultrasound Diagnoses of Ovarian Cancer: A Systematic Review and Meta-Analysis. Cancers, 16, Article No. 422. [Google Scholar] [CrossRef] [PubMed]
[41] Li, R., Lei, J., Tang, X., Zheng, S., Qu, J., Xu, Y., et al. (2025) Artificial Intelligence Based on Ultrasound for Initial Diagnosis of Malignant Ovarian Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 15, Article ID: 1626286. [Google Scholar] [CrossRef
[42] Moffitt, L.R., Karimnia, N., Wilson, A.L., Stephens, A.N., Ho, G. and Bilandzic, M. (2024) Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer. Current Oncology, 31, 8023-8038. [Google Scholar] [CrossRef] [PubMed]
[43] Zeng, S., Wang, X. and Yang, H. (2024) Radiomics and Radiogenomics: Extracting More Information from Medical Images for the Diagnosis and Prognostic Prediction of Ovarian Cancer. Military Medical Research, 11, Article No. 77. [Google Scholar] [CrossRef] [PubMed]